These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26511868)

  • 1. Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.
    Virdi V; Juarez P; Boudolf V; Depicker A
    Cell Mol Life Sci; 2016 Feb; 73(3):535-45. PubMed ID: 26511868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant immunoglobulin A: powerful tools for fundamental and applied research.
    Corthésy B
    Trends Biotechnol; 2002 Feb; 20(2):65-71. PubMed ID: 11814596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant secretory immunoglobulin A in passive immunotherapy: linking immunology and biotechnology.
    Corthésy B
    Curr Pharm Biotechnol; 2003 Feb; 4(1):51-67. PubMed ID: 12570682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant secretory IgA for immune intervention against mucosal pathogens.
    Corthésy B
    Biochem Soc Trans; 1997 May; 25(2):471-5. PubMed ID: 9191138
    [No Abstract]   [Full Text] [Related]  

  • 5. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory immunoglobulin A: from mucosal protection to vaccine development.
    Corthésy B; Spertini F
    Biol Chem; 1999 Nov; 380(11):1251-62. PubMed ID: 10614817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody.
    Saito S; Sano K; Suzuki T; Ainai A; Taga Y; Ueno T; Tabata K; Saito K; Wada Y; Ohara Y; Takeyama H; Odagiri T; Kageyama T; Ogawa-Goto K; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    PLoS Pathog; 2019 Jan; 15(1):e1007427. PubMed ID: 30605488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of IgA in local immune protection.
    Goldblum RM
    J Clin Immunol; 1990 Nov; 10(6 Suppl):64S-70S; discussion 70S-71S. PubMed ID: 2081792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
    Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S
    J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizon of mucosal immunity and vaccines.
    Takahashi I; Nochi T; Yuki Y; Kiyono H
    Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Secretory IgA in the Mucosal Immune System.
    Li Y; Jin L; Chen T
    Biomed Res Int; 2020; 2020():2032057. PubMed ID: 31998782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.
    Eijgenraam JW; Oortwijn BD; Kamerling SW; de Fijter JW; van den Wall Bake AW; Daha MR; van Kooten C
    Clin Exp Immunol; 2008 May; 152(2):227-32. PubMed ID: 18336594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of secretory immunity and memory at mucosal surfaces.
    Brandtzaeg P
    Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography.
    Moldt B; Saye-Francisco K; Schultz N; Burton DR; Hessell AJ
    Methods; 2014 Jan; 65(1):127-32. PubMed ID: 23811333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M cell-targeted ocular immunization: effect on immunoglobulins in tears, feces, and serum.
    Phillips TE; Sharp J; Rodgers K; Liu H
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1533-9. PubMed ID: 19892871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant mucosal sIgA production after a single oral or parenteral administration using in vivo CD40 targeting in the chicken.
    Chou WK; Chen CH; Vuong CN; Abi-Ghanem D; Waghela SD; Mwangi W; Bielke LR; Hargis BM; Berghman LR
    Res Vet Sci; 2016 Oct; 108():112-5. PubMed ID: 27663378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the mucosal immune response.
    Russell MW; Mestecky J
    Rev Infect Dis; 1988; 10 Suppl 2():S440-6. PubMed ID: 3055213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of secretory antibodies in the defence against infections.
    Brandtzaeg P
    Int J Med Microbiol; 2003 Apr; 293(1):3-15. PubMed ID: 12755363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.